Comparison of GLP-1 Analogues versus Sitagliptin in the Management of Type 2 Diabetes: Systematic Review and Meta-Analysis of Head-to-Head Studies

BACKGROUND: Incretin–based therapies which include glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors are recommended by several practice guidelines as second-line agents for add-on therapy to metformin in patients with type 2 diabetes (T2DM) who do not a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Tiansheng, Gou, Zhuoyue, Wang, Fei, Ma, Manling, Zhai, Suo-di
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121242/
https://ncbi.nlm.nih.gov/pubmed/25089625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0103798
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados